Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus. - Wikidata - wikimedia - TriplyDB

Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus.

Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus.

http://www.wikidata.org/entity/Q37320205

about

Treatment for peritoneal dialysis-associated peritonitis Treatment for peritoneal dialysis-associated peritonitis Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage Multidrug-resistant Acinetobacter baumannii Confounding by indication affects antimicrobial risk factors for methicillin-resistant Staphylococcus aureus but not vancomycin-resistant enterococci acquisition Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients.Case-case-control study on factors associated with vanB vancomycin-resistant and vancomycin-susceptible enterococcal bacteraemia.Outbreak of vancomycin-resistant enterococcus colonization among pediatric oncology patients Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study.Impact of peri-transplant vancomycin and fluoroquinolone administration on rates of bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients: a 12-year single institution study.Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.Nasal and perirectal colonization of vancomycin sensitive and resistant enterococci in patients of paediatrics ICU (PICU) of tertiary health care facilities A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.Enterococcus faecalis prophage dynamics and contributions to pathogenic traits Antimicrobial Use and Resistance.Ecological modeling from time-series inference: insight into dynamics and stability of intestinal microbiota In vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria Epidemiology of hospital-acquired urinary tract-related bloodstream infection at a university hospital.Viral warts in organ transplant recipients: new aspects in therapy.Reference group choice and antibiotic resistance outcomes.Colonization with antibiotic-susceptible strains protects against methicillin-resistant Staphylococcus aureus but not vancomycin-resistant enterococci acquisition: a nested case-control study.Resistance to antimicrobial agents: an update.Methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci in rural communities, western United States.Laboratory-based evaluation of MDR strains of Pseudomonas in patients with acute burn injuries Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK.Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update.Epidemiology of vancomycin-resistant Enterococcus faecalis: a case-case-control study.Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance Causative Organisms and Associated Antimicrobial Resistance in Healthcare-Associated, Central Line-Associated Bloodstream Infections From Oncology Settings, 2009-2012.Longer intestinal persistence of Enterococcus faecalis compared to Enterococcus faecium clones in intensive-care-unit patients.Incidence and risk factors of infection caused by vancomycin-resistant enterococcus colonization in neurosurgical intensive care unit patients.Role of matching in case-control studies of antimicrobial resistance.BReast Ecology Assessment in the STudy of local MicroFlora - Study Protocol.Temporal trends and risk factors for healthcare-associated vancomycin-resistant enterococci in adults.Prevalence and risk factors for VRE colonisation in a tertiary hospital in Melbourne, Australia: a cross sectional study.The role of antimicrobial stewardship in curbing carbapenem resistance.Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients.Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes.The clinical and molecular epidemiology of pre-transplant vancomycin-resistant enterococci colonization among liver transplant recipients.Vancomycin-resistant enterococcus (VRE) transmission and risk factors in contacts of VRE carriers.

P2860

Q24195002-38A170B8-A201-45B6-9040-143F0838E1C3 Q24242227-456AD4D8-B08C-4C4D-8C70-CD572558B045 Q28268161-697C2E47-82A9-4B62-8635-3D5C614F6D94 Q28306885-85FCC148-7DFD-417B-A395-CF4BD4B87F27 Q33756510-25508C5E-D908-44AF-8596-5350942CCD63 Q33826293-426BB8DE-79A3-4ADE-8899-5DD9646994F5 Q33880518-1FA1660A-6EF9-43EA-BF43-CD0D883D723E Q33978474-A0152A6D-CEC2-45E2-8BAD-F68959BD66B9 Q34123634-DE9999E0-E4F8-4A16-8F78-939F55DD493F Q34175284-692A0A1E-6842-4502-B710-F3AA54B62C32 Q34301559-45B47B03-D23C-4A6C-A323-59156B70D6CA Q34640030-C7BE1C21-1F32-4403-988E-3FB7BF89F39A Q34643123-3CF9B64B-ECA4-409F-A929-562182EE3A99 Q34765413-82B3B426-6CAC-48B7-AA40-83F68E2CFCE6 Q34998303-9E1CDA25-0987-49A8-8B6B-58E4E8DD12AA Q35069150-AFC3E7B0-C2DD-402D-9283-730D854F1005 Q35103522-6FBC6B4A-D7BF-4C3D-A239-130D52E35901 Q35414615-40ECA765-4F3F-4615-AAA9-F0CC34F146AF Q35583156-5A5C0645-EA7C-48C4-B137-43B321652BF9 Q35880537-A83C5DE7-45D3-4AD6-87EA-597E63B059B0 Q35908101-38B0212A-03F8-4ACE-B213-3A29DC3C9E27 Q35976850-618CCFAE-A645-4F7B-86B2-31B86CD2A8A3 Q36009339-9423B3CB-89D4-4662-83B0-2B048740DE72 Q36318055-F31A7CC8-B0E6-443D-85F5-B9194E7B48EA Q36409465-6B7E0BD7-9196-41E2-96EA-FF8CAB0F6ACD Q36474366-16DBF36D-BB43-448A-BF71-2F20F984DCB8 Q36505351-2B34FD73-F990-41FF-B1B9-8EAB92F297A8 Q36757737-37CEAE35-AE4A-4823-BF2B-1F57018C87CB Q36973200-B3BC7054-A1B9-48E5-90FE-D7E59F1737FE Q37099648-C0DD3AB8-5345-4067-8DA5-B0B5190FC14D Q37346968-F519FAAF-3146-4742-A33B-258A4FC5F902 Q37399052-0C58DD7C-E94D-4B40-8F36-8AB48CD97DFC Q37441552-C3FCAB51-2687-408B-9CC9-5D7039510670 Q37539680-55500E6C-8956-41B3-B966-C5C6CEC19F9C Q38049612-FC43514D-C31D-451A-8CD1-19A01D5BF21A Q38125493-26D803E0-6019-4A4A-B4E1-CAE19C9E93A5 Q38126225-6C9D8AA4-82B7-436B-8B03-3B47CC0436B9 Q38461269-93E39519-4EFD-404C-85E7-155A62EC9AD8 Q40828436-B56976FD-743C-4B70-B7C5-0A95A677FDD1 Q42211167-EFFC3298-97C9-4FB6-B628-AB3EB2F87D8D

P2860

Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus.

http://www.wikidata.org/entity/Q37320205

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2002

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Antecedent treatment with diff ...... omycin-resistant Enterococcus.

@en

Antecedent treatment with diff ...... omycin-resistant Enterococcus.

@nl

type

label

Antecedent treatment with diff ...... omycin-resistant Enterococcus.

@en

Antecedent treatment with diff ...... omycin-resistant Enterococcus.

@nl

prefLabel

Antecedent treatment with diff ...... omycin-resistant Enterococcus.

@en

Antecedent treatment with diff ...... omycin-resistant Enterococcus.

@nl

P1433

Q37320205-BB9B6675-5F43-4D6C-B68E-3965D5A5EEC6

P1476

Q37320205-D8C5EC2B-C3EC-47E4-A2EE-11966E23C97E

P2093

Q37320205-18F083AB-6064-4AD6-A437-EA6D520BFAC5

Q37320205-1BCC753F-08BB-4388-B871-F3ACCADE37AA

Q37320205-BB4C9D29-8019-46B1-8FF2-54E85AF9D663

P2860

Q37320205-08789A61-F48C-4E7F-8E76-49C8B6D51F1C

Q37320205-1CAE9018-55E3-479E-BCA2-8A239F35C231

Q37320205-290632F5-C6F7-4E4D-9DE5-617791F99B47

Q37320205-418A1D08-90F1-467E-8087-2A17552FCB24

Q37320205-56AF3938-796E-4550-B409-7BFA2F016B5B

Q37320205-78258D4E-D59F-422C-9104-4A4362FB0BF2

Q37320205-79693CE6-D8D0-459A-BDB3-5E439B0C0FEB

Q37320205-7E875FEA-0891-4EEA-A4FB-9B34FC0A879E

Q37320205-8782DF8C-6977-40A1-B05D-9AE40779002F

Q37320205-90AD0AD2-48E4-4461-B89A-A6B7427A08D9

P304

Q37320205-7DDCD3E8-7083-4B81-BAF6-4889D3CFC56B

P31

Q37320205-9B19E0E5-0BB9-43DF-9AAA-E1D859361D6F

P356

Q37320205-5FAE8133-D43A-4FCF-ACCE-4CA937530562

P433

Q37320205-8A32DB9F-1057-420B-9017-5D1C1F7AFF2E

P478

Q37320205-CA77BF54-C95A-4973-9A32-925989606FBA

P577

Q37320205-5A7D091E-6AB4-4C81-A17A-C7A892153EAB

P698

Q37320205-BA2F8E07-4ED5-45C0-BE25-E4020B303154

P921

Q37320205-8CDB3890-347F-41CD-BE32-3DD0BA47E46E

Q37320205-D29AE846-94EC-4E4C-BCEE-3DBE3C76C5C1

P932

Q37320205-96FF17F0-A6BB-43E8-A216-1D97F3D1B9C5

P356

P1433

Emerging Infectious Diseases

P1476

Antecedent treatment with diff ...... omycin-resistant Enterococcus.

@en

P2093

George M Eliopoulos

http://www.w3.org/2001/XMLSchema#string

Matthew H Samore

http://www.w3.org/2001/XMLSchema#string

Yehuda Carmeli

http://www.w3.org/2001/XMLSchema#string

P2860

A clinical data repository enhances hospital infection control

Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli.

Vancomycin-resistant enterococcal infections.

Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review.

Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci

Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients

A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit.

Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs.

Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance

A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit.

P304

802-807

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3201/EID0808.010418

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2002-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12141965

http://www.w3.org/2001/XMLSchema#string

P921

antibiotic resistance

P932

2732508

http://www.w3.org/2001/XMLSchema#string